Pricing Log in Create free account

Absci Corporation (ABSI) vs Nanobiotix S.A. - Sponsored ADR (NBTX)

Absci Corporation and Nanobiotix S.A. - Sponsored ADR are both Biotechnology companies. Absci Corporation and Nanobiotix S.A. - Sponsored ADR are of similar size ($1.7B and $1.7B). Nanobiotix S.A. - Sponsored ADR has the higher net margin (0.00% vs −7,756.4%) and the higher return on invested capital (0.00% vs −174.7%). Across the 16 metrics below, Nanobiotix S.A. - Sponsored ADR leads on 9 and Absci Corporation on 7.

Valuation

Metric ABSI NBTX Biotechnology median
P/E n/m n/m 11.58
P/S 1,015.85 6,561.33 9.61
P/B 6.44 n/m 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 887.13 5,805.83 9.43
Earnings yield (7.94%) (10.11%) (32.28%)
Free cash flow yield (6.86%) (12.74%) (22.27%)

Profitability

Metric ABSI NBTX Biotechnology median
Gross margin 100.00% 0.00% 68.81%
Operating margin (8,084.50%) 0.00% 0.00%
Net margin (7,756.37%) 0.00% 0.00%
Free cash flow margin (6,969.83%) 0.00% 0.00%
Return on equity (57.72%) 0.00% (50.30%)
Return on assets (50.57%) 0.00% (45.47%)
Return on invested capital (174.74%) 0.00% 0.00%

Growth

Metric ABSI NBTX Biotechnology median
Revenue growth (TTM) (62.28%) — 6.78%
EPS growth (last fiscal year) 10.64% 63.46% 29.88%
Revenue growth, 5-year CAGR (10.14%) 66.64% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABSI NBTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.63 1.44 4.74
Net debt to EBITDA 1.32 5.66 1.01

Dividend

Metric ABSI NBTX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ABSI NBTX Biotechnology median
Market cap 1.74b 1.68b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack